The global peripheral vascular devices market is witnessing significant transformation as healthcare systems increasingly focus on early diagnosis, minimally invasive treatment, and improved management of peripheral vascular diseases. The growing prevalence of peripheral arterial disease (PAD), venous disorders, aneurysms, and other vascular conditions is creating sustained demand for advanced intervention technologies. At the same time, an aging global population and the rising burden of lifestyle-related conditions such as diabetes and obesity are increasing the number of patients requiring vascular diagnosis and treatment.
According to Grand View Research, the global peripheral vascular devices market was valued at USD 9.5 billion in 2025 and is estimated to reach USD 10.2 billion in 2026. The market is projected to reach USD 16.1 billion by 2033, expanding at a CAGR of 6.6% from 2026 to 2033. The continued expansion reflects growing clinical adoption of endovascular procedures, technological advancements in vascular devices, and increasing investments in healthcare infrastructure.
Rising Burden of Peripheral Arterial Disease Driving Demand
One of the strongest factors supporting market expansion is the growing burden of Peripheral Arterial Disease (PAD). PAD affects blood flow to the limbs and is strongly associated with risk factors such as diabetes, obesity, smoking, cardiovascular disease, and aging. The increasing prevalence of these conditions is creating greater demand for effective diagnostic and treatment solutions.
Grand View Research highlights that the global prevalence of PAD is projected to rise by approximately 220% by 2050, reaching around 360 million cases. More than half of these cases are expected to occur in low- and middle-income countries. This growing disease burden is expected to increase demand for peripheral stents, angioplasty balloons, catheters, atherectomy devices, and other vascular intervention technologies.
Shift Toward Minimally Invasive Vascular Procedures
Another important trend shaping the peripheral vascular devices industry is the increasing preference for minimally invasive catheter-based revascularization procedures. Compared with conventional open surgery, endovascular procedures can offer lower procedural risks, shorter hospital stays, and faster recovery.
Angioplasty, stenting, atherectomy, and other catheter-based interventions are therefore becoming increasingly important in the treatment of peripheral vascular conditions. Technological improvements are also allowing physicians to treat increasingly complex lesions while improving device deliverability and procedural outcomes.
This shift toward less invasive interventions is creating opportunities for manufacturers to develop more flexible, lower-profile, and technologically advanced devices designed for complex vascular anatomies.
Peripheral Stents Remain a Major Product Segment
By type, peripheral stents accounted for 22.2% of the market in 2025, making them the leading product segment. Peripheral stents are used to reopen arteries narrowed or blocked by plaque and are benefiting from continuing innovation in vascular intervention technologies.
Manufacturers are increasingly developing advanced stent platforms designed to improve vessel patency and clinical outcomes. Drug-eluting technologies, resorbable scaffolds, and other next-generation approaches are expanding the range of treatment options available to physicians.
At the same time, peripheral accessories are expected to register the fastest CAGR during the forecast period. Increasing procedure volumes and the growing adoption of minimally invasive interventions are supporting demand for guidewires, vascular closure devices, balloon inflation devices, and introducer sheaths.
PAD Represents the Largest Application Segment
From an application perspective, Peripheral Arterial Disease (PAD) held the largest share of 46.6% in 2025. Rising disease prevalence, increasing research activity, and improvements in diagnostic and treatment technologies are supporting this segment.
The aneurysms segment, meanwhile, is expected to grow at the fastest CAGR during the forecast period. Increasing incidence among older populations and risk factors such as smoking are contributing to demand for effective aneurysm screening and intervention solutions.
Hospitals Lead While Ambulatory Surgical Centers Gain Momentum
Hospitals remained the largest end-use segment in 2025, supported by their access to specialized vascular units, advanced imaging systems, and trained medical professionals. Hospitals continue to perform complex peripheral vascular procedures requiring sophisticated infrastructure.
However, ambulatory surgical centers (ASCs) are expected to record the fastest CAGR during the forecast period. The movement toward outpatient and minimally invasive procedures, combined with efforts to control healthcare costs and reduce hospital stays, is encouraging the migration of selected vascular interventions toward ASCs.
This transition could significantly influence device purchasing patterns as healthcare providers increasingly seek efficient treatment environments without compromising procedural safety.
North America Maintains Market Leadership
North America dominated the global peripheral vascular devices market in 2025, accounting for 47.1% of revenue. The region benefits from advanced healthcare infrastructure, high technology adoption, significant healthcare expenditure, and a substantial patient population affected by PAD.
The U.S. represents a particularly important market. According to data cited by Grand View Research, approximately 6.5 million people aged 40 and older in the U.S. are affected by PAD. The combination of disease prevalence, advanced vascular intervention capabilities, and ongoing product innovation is expected to sustain regional demand.
Asia Pacific Emerges as the Fastest-Growing Region
While North America currently leads the industry, Asia Pacific is expected to register the fastest CAGR from 2026 to 2033. Increasing healthcare infrastructure investment, a growing burden of vascular diseases, and greater access to advanced treatment technologies are creating significant opportunities across the region.
Countries such as China, India, and Japan are becoming increasingly important as healthcare systems expand their capacity for vascular diagnosis and intervention. Manufacturers are also focusing on strengthening their regional manufacturing, research, distribution, and commercialization capabilities.
Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.
Technology and Product Innovation Shape Competition
Technological innovation remains a major competitive factor. Companies are investing in drug-coated balloons, drug-eluting stents, bioresorbable scaffolds, advanced grafts, and intravascular lithotripsy systems to address complex vascular conditions and improve patient outcomes.
Recent developments illustrate this trend. In September 2025, Johnson & Johnson launched the Shockwave Javelin Peripheral IVL Catheter in Europe, designed to address calcification in severely narrowed vessels. Abbott also received CE Mark approval for its Esprit BTK Everolimus Eluting Resorbable Scaffold System, representing continued innovation in below-the-knee PAD treatment.
Competitive Landscape
The peripheral vascular devices industry features several established medical technology companies competing through product innovation, strategic partnerships, acquisitions, clinical studies, and portfolio expansion.
Key Peripheral Vascular Devices Companies:
The following key companies have been profiled for this study on the peripheral vascular devices market.
• Abbott
• Koninklijke Philips N.V.
• Edward Lifesciences Corporation
• Medtronic
• Teleflex Incorporated
• Boston Scientific Corporation
• BD
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Cordis
• Cook Group
• B. Braun SE
As companies continue introducing next-generation devices and expanding into emerging markets, competition is expected to remain focused on clinical performance, technological differentiation, regulatory approvals, and minimally invasive treatment capabilities.
Explore our dedicated business services:
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.
About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.
